Study Details

Back
Study ID 9766-CL-0103
Study Title Open-Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Clinicaltrials.gov Identifier NCT00634049
Compound Name BAL8557 / isavuconazonium sulfate
Medical Indication or Disease Invasive fungal infection
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Basilea Pharmaceutica International, Ltd.
Study Start Date 22-Apr-2008
Study Completion Date 05-May-2016
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS